If a patient has a limited number of brain metastases (e.g., <3 total) but the additive volume of these intracranial metastases is high (e.g., each lesion is 100 cc to 125 cc, such that the total volume is ~400 cc), do you selectively employ WBRT versus SRS?
If so, what is the total volume of intracranial metastatic disease that serves as a cutoff between SRS vs. WBRT approaches to palliation?
Thanks for quoting our dose algorithm from Yale - ...
With the exception of small cell lung cancer, I ag...